The Regenerative Medicine Institute (REMEDI) at NUI Galway was delighted to host a visit by winning essay writers from St Nathy’s College, Ballaghdereen, Co. Roscommon. Each of the winning students had written an essay on the topic of stem cell, outlining the history of their discovery, and their potential to revolutionise the treatment of a […]
Author Archive for: visicort_admin
This author has yet to write their bio.Meanwhile lets just say that we are proud visicort_admin contributed a whooping 58 entries.
Entries by visicort_admin
VISICORT has produced a new brochure to promote the project, and to explain its aims, objectives, and approach to a general audience. Copies of the brochure can be downloaded here.
A recently published study in Transplantation Proceedings presents changing trends in corneal transplantation (CT) from Italy. The Corneal Transplant Epidemiological Study (CORTES) presents seven years of data, 2002 to 2008, from a prospective study which included over 13,000 CT. In general, trends were driven by changing clinical practise and mirrored similar trends observed in Western […]
A recent study from one of the five clinical sites for VISICORT, Bristol Eye Hospital, reports that systemic immunosuppression appears to improve long-term graft survival in corneal transplants at high risk of rejection.1 Lead author of the study, Dr Sing-Pey Chow, reports: Immunological graft rejection remains the leading cause of graft failure in corneal transplantation. […]
New data from UK Transplant Registry shows similar 2-year rejection rates for full thickness and endothelial corneal transplants in first-time recipients Corneal transplantation involves the replacement of damaged cornea with donor tissue. For some of the commonest forms of corneal disease, there are currently two primary approaches to transplantation: Full-thickness, or penetrating keratoplasty (PK), which […]
The Medical Times and the Irish College of Ophthalmologists announce the commencement of recruitment for the VISICORT trial.
VISICORT partners NUI Galway, Orbsen, and Pintail are involved in NEPHSTROM, a new European project, which was launched last week. NEPHSTROM involves eleven partners from Ireland, the UK, Germany, and the Netherlands, and has received €6 million funding under the European Union’s Horizon 2020 funding programme. NEPHSTROM will evaluate the clinical safety and efficacy of […]
Our sister project REDDSTAR and Leiden University Medical Center are co-organizing EU MSC2 2015, a meeting in Leiden, NL on September 7th and 8th to bring together nine EU-funded, mesenchymal stromal cell-focussed consortia. Projects include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2. This two day, interactive meeting will be held at the […]
The VISICORT project marked the end of the first year of its work with a plenary meeting at the Charité Campus Virchow Klinikum in Berlin on Friday, May 29. Following an overview of the management of the project, scientists involved in the project’s preclinical workpackages reported on the research carried out in the six months […]
In a major step forward for the project, the first VISICORT sampling kits were shipped to clinical centres in Dublin and Aarhus this week from partner Biostor. Managing, sourcing and assembling the final sampling kits has involved a huge effort from Niall, Peadar and all the team at Biostor.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602470. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.